Furazolidone-induced pulmonary toxicity in Helicobacter pylori infection: Two case reports

World J Clin Cases. 2023 Apr 26;11(12):2832-2838. doi: 10.12998/wjcc.v11.i12.2832.

Abstract

Background: Helicobacter pylori (H. pylori) infection is a global problem, causing significant morbidity and mortality. Furazolidone is recommended to eradicate H. pylori infections in China owing to the highly associated antibiotic resistance.

Case summary: This article presents two cases of lung injury caused by furazolidone treatment of H. pylori infection and the relevant literature review. Two patients developed symptoms, including fever, cough, and fatigue after receiving a course of furazolidone for H. pylori infection. Chest computed tomography showed bilateral interstitial infiltrates. Laboratory studies revealed elevated blood eosinophil count. After discontinuing furazolidone with or without the use of corticosteroids, the symptoms improved rapidly. A PubMed database literature search revealed three reported cases of lung injury suggestive of furazolidone-induced pulmonary toxicity.

Conclusion: Clinicians should be aware of the side effects associated with the administration of furazolidone to eradicate H. pylori infection.

Keywords: Case report; Furazolidone; Helicobacter pylori infection; Pulmonary hypersensitivity.

Publication types

  • Case Reports